Skip to main content
. 2020 Nov 13;13:532. doi: 10.1186/s13104-020-05376-9

Table 2.

The correlation of PD-L1 with chemokines and cytokines in periodontally diseased and periodontally healthy control subjects

Comparison Estimated correlation Lower bound 95% CI Upper bound 95% CI p-valuea
Healthy sites in periodontally diseased and periodontally healthy control subjects (N = 31)
 PD-L1 vs IL6 − 0.35 − 0.63 0.00 0.05
 PD-L1 vs CXCL8 − 0.56 − 0.76 − 0.26 0.001
 PD-L1 vs IL10 − 0.43 − 0.68 − 0.09 0.02
 PD-L1 vs CCL3 − 0.37 − 0.64 − 0.01 0.04
Diseased sites in periodontally diseased subjects (N = 20)
 PD-L1 vs CCL11 0.51 0.09 0.78 0.02
 PD-L1 vs CSF2 0.69 0.36 0.87 0.001
 PD-L1 vs IFNG 0.49 0.06 0.77 0.03
 PD-L1 vs IL12A − 0.54 − 0.79 − 0.13 0.01
PD-L1 vs IL1A 0.46 0.03 0.75 0.04
PD-L1 vs IL1B 0.56 0.15 0.80 0.01
PD-L1 vs IL2 0.50 0.07 0.77 0.03
PD-L1 vs IRX1 − 0.55 − 0.80 − 0.15 0.01
PD-L1 vs IL7 0.61 0.23 0.83 0.004
PD-L1 vs IL15 0.64 0.27 0.84 0.003
PD-L1 vs CCL5 0.50 0.07 0.77 0.03

Taken from, the 37 healthy sites in 19 periodontally diseased subjects and the 48 healthy sites in 12 periodontally healthy control subjects

aPearson’s correlation